
ŌURA Snags $200M, Hits $5.2B Valuation
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round. The post ŌURA Snags $200M, Hits $5.2B Valuation appeared first on MedCity News.
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round. The post ŌURA Snags $200M, Hits $5.2B Valuation appeared first on MedCity News.
U.S. healthcare organizations lose $1.9 million on average during each day of downtime following a ransomware attack, according to new research from Comparitech. Rebecca Moody, Comparitech’s head of data research, predicted that the rate of ransomware attacks in the healthcare sector will accelerate even more in 2025. The post Healthcare Providers Lose Nearly $2M Per…
These benefits set employees up with the resources and access to manage their health efficiently and proactively while giving employers financial savings throughout the year. The post The Benefits Hierarchy of Needs: Why Employers & Payers Should Prioritize Gut Health Benefits appeared first on MedCity News.
In its final operational year, OneCare Vermont said it is committed to supporting its participant network in achieving shared cost and quality goals
The public health community can circle the wagons and complain about the attacking forces outside. Alternatively, public health advocates can take a hard look in the mirror, get outside of their bubble, frankly identify failures and missteps, and determine how to regain the trust of an increasingly skeptical public. The post Public Health’s Proudest Moment…
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Cybersecurity experts predict cybersecurity attacks will continue to happen with more sophistication
President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for AI and cryptocurrency. Ryan Tarzy — CEO of Avandra Imaging, a federated network for de-identified imaging data — thinks this appointment could help accelerate the pace of innovation in the healthcare industry. The post Why One Startup CEO…
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on…
Bill Hall, 71, has been fighting for his life for 38 years. These days, he’s feeling worn out. Hall contracted HIV, the virus that can cause AIDS, in 1986. Since then, he’s battled depression, heart disease, diabetes, non-Hodgkin lymphoma, kidney cancer, and prostate cancer. This past year, Hall has been hospitalized five times with dangerous…